Xiaoyun Xing

Senior Scientist

University of Washington
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (9)

Year:

2026

Year:

2025

Exposure to toxic substances, particularly early in life, can perturb epigenomic marks linked to disease susceptibility. Human studies of environmental exposures often rely on surrogate tissues such as blood, but toxicant accumulation differs across organs and results in tissue-specific responses. Thus, understanding whether exposure-induced epigenomic alterations in surrogate tissues such as blood reflect changes in toxicant target tissues, such as liver, is essential for designing and interpreting environmental epigenetic studies. To address this knowledge gap, we systematically analyzed 1,013 multi-omics data from the TaRGET II Consortium, comparing molecular responses in mouse liver and blood following perinatal exposure to arsenic, lead, bisphenol A, tributyltin, di-2-ethylhexyl phthalate, tetrachlorodibenzo-p-dioxin, or air pollution in the form of particulate matter < 2.5µm (PM2.5). Most toxicant-induced molecular changes were tissue-specific, yet we identified a subset of co-regulated genes and regulatory elements in liver and blood in response to early-life exposure to toxicants. Moreover, we discovered that specific pathways, such as immune-related processes, were commonly affected by exposures in both tissues, and transcription factors, including Klf , Jun , Ets1 , and Cebp , emerged as shared regulators. While molecular alterations are infrequently conserved between tissues following toxicant exposure, the shared alterations in transcription factors and biological pathways may provide a strategy to link effects in surrogate tissues to target tissues.

Year:

2025

Environmental exposures to toxic chemicals can profoundly alter the transcriptome and epigenome in both humans and animals, contributing to disease development across the lifespan. To elucidate how early-life exposure to toxicants exerts such persistent effects, the Toxicant Exposures and Responses by Genomic and Epigenomic Regulators of Transcription II (TaRGET II) Consortium generated a landmark resource comprising 2,570 epigenomes and 1,043 transcriptomes from longitudinal studies in mice. All data are publicly available through the TaRGET II data portal and the WashU Epigenome Browser. This resource from target (liver, brain, lung, heart) and surrogate (blood) tissues at weaning (3 weeks) and two adult time-points (5 and 10 months) characterized the molecular response to arsenic (As), lead (Pb), bisphenol-A (BPA), di-2-ethylhexyl phthalate(DEHP), tributyltin (TBT), tetrachlorodibenzo-p-dioxin (TCDD), and particulate matter with a diameter of <2.5μm (PM2.5). The findings revealed persistent, toxicant-specific, sex-dependent epigenomic and transcriptomic perturbations, resulting in disrupted expression of 14,908 genes, altered chromatin accessibility at 87,409 regulatory elements, DNA methylation changes at 113,186 genomic regions, and chromatin state switching of histone modifications. The resulting high-resolution map of how environmental exposures reprogram the epigenome and transcriptome is broadly accessible via ToxiTaRGET database, offering unparalleled opportunities for the scientific community to investigate the molecular underpinnings of environmental toxicant exposures and their contributions to disease pathogenesis.

Year:

2025

Comparative genomics has revealed the rapid expansion of multiple gene families involved in immunity. Members within each gene family often evolved distinct roles in immunity. However, less is known about the evolution of their epigenome and cis -regulation. Here we systematically profile the epigenome of the recently expanded murine Ly49 gene family that mainly encode either inhibitory or activating surface receptors on natural killer cells. We identify a set of cis -regulatory elements (CREs) for activating Ly49 genes. In addition, we show that in mice, inhibitory and activating Ly49 genes are regulated by two separate sets of proximal CREs, likely resulting from lineage-specific losses of CRE activity. Furthermore, we find that some Ly49 genes are cross-regulated by the CREs of other Ly49 genes, suggesting that the Ly49 family has begun to evolve a concerted cis- regulatory mechanism. Collectively, we demonstrate the different modes of cis -regulatory evolution for a rapidly expanding gene family.

Year:

2024

Year:

2023

Epigenetic alterations are widespread in cancer and can complement genetic alterations to influence cancer progression and treatment outcome. To determine the potential contribution of DNA methylation alterations to tumor phenotype in non-small cell lung cancer (NSCLC) in both smoker and never-smoker patients, we performed genome-wide profiling of DNA methylation in 17 primary NSCLC tumors and 10 matched normal lung samples using the complementary assays, methylated DNA immunoprecipitation sequencing (MeDIP-seq) and methylation sensitive restriction enzyme sequencing (MRE-seq). We reported recurrent methylation changes in the promoters of several genes, many previously implicated in cancer, including FAM83A and SEPT9 (hypomethylation), as well as PCDH7, NKX2-1, and SOX17 (hypermethylation). Although many methylation changes between tumors and their paired normal samples were shared across patients, several were specific to a particular smoking status. For example, never-smokers displayed a greater proportion of hypomethylated differentially methylated regions (hypoDMRs) and a greater number of recurrently hypomethylated promoters, including those of ASPSCR1, TOP2A, DPP9, and USP39, all previously linked to cancer. Changes outside of promoters were also widespread and often recurrent, particularly methylation loss over repetitive elements, highly enriched for ERV1 subfamilies. Recurrent hypoDMRs were enriched for several transcription factor binding motifs, often for genes involved in signaling and cell proliferation. For example, 71% of recurrent promoter hypoDMRs contained a motif for NKX2-1. Finally, the majority of DMRs were located within an active chromatin state in tissues profiled using the Roadmap Epigenomics data, suggesting that methylation changes may contribute to altered regulatory programs through the adaptation of cell type-specific expression programs.

Year:

2023

Year:

2023

Year:

2023

Collaborators (12)

Hyung Joo Lee

-

UNITED STATES
View details

Bo Zhang

Associate Professor

Washington University in St. Louis

UNITED STATES
View details

Sandra Grimm

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details

Naresha Saligrama

Assistant Professor

Washington University in Saint Louis School of Medicine

UNITED STATES
View details

Ting Wang

Washington University School of Medicine

UNITED STATES
View details

Elisha Roberson

Assistant Professor

Washington University in Saint Louis School of Medicine

UNITED STATES
View details

Cristian Coarfa

Baylor College of Medicine

UNITED STATES
View details

Mark Watson

Professor

Washington University in Saint Louis School of Medicine

UNITED STATES
View details

Valerie O'Brien

Assistant Profesor

Purdue University

UNITED STATES
View details

Marisa Bartolomei

University of Pennsylvania Perelman School of Medicine

UNITED STATES
View details

Ming Hu

Associate Staff

Cleveland Clinic

UNITED STATES
View details

Daofeng Li

Assistant Professor

Washington University in St. Louis

UNITED STATES
View details